Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA polymerase I transcription factor homolog pseudogene 1 (RRN3P1) is a non-protein-coding pseudogene in humans, predicted to share sequence similarity with the RRN3 transcription factor, which assists in the initiation of transcription by RNA polymerase I[1][2][10]. RRN3P1 is not known to produce a functional product in humans and is most useful for comparative genomics or understanding regulatory noncoding RNA elements. Unlike the functional RRN3 gene, which is involved in ribosomal RNA synthesis and associated with some diseases, RRN3P1 has no known clinical significance, therapeutic relevance, or drug interactions. Most databases classify RRN3P1 among pseudogenes, and there is no evidence supporting its targeting in therapy or diagnostics[1][2][6][10].
None (No recognized mechanism because no drugs target RRN3P1.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase I transcription factor homolog pseudogene 1 (RRN3P1).